WithdrawnNCT02046551
Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
Medication studyAges 18–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2014
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02046551
- Official title
Show the full official title
Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
Recruitment & locations
WithdrawnWest Haven
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Atomoxetine and Placebo.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
